Trial Profile
Single Arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Liver Cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2019
Price :
$35
*
At a glance
- Drugs Anti-EPCAM-CAR-T-cell-therapy-Sinobioway-Cell-Therapy (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms EECLC
- Sponsors Sinobioway Cell Therapy
- 17 Mar 2017 New trial record